Concord Wealth Partners’s Halozyme HALO Stock Holding History

Concord Wealth Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-66	Closed	-$4.44K	–	442
2025 Q4	$4.44K	Hold	66	–	–	﹤0.01%	639
2025 Q3	$4.84K	Hold	66	–	–	﹤0.01%	628
2025 Q2	$3.43K	Hold	66	–	–	﹤0.01%	677
2025 Q1	$4.21K	Hold	66	–	–	﹤0.01%	606
2024 Q4	$3.15K	Hold	66	–	–	﹤0.01%	658
2024 Q3	$3.78K	Hold	66	–	–	﹤0.01%	674
2024 Q2	$3.46K	Hold	66	–	–	﹤0.01%	617
2024 Q1	$2.69K	Hold	66	–	–	﹤0.01%	721
2023 Q4	$2.44K	Hold	66	–	–	﹤0.01%	695
2023 Q3	$2.52K	Hold	66	–	–	﹤0.01%	837
2023 Q2	$2.38K	Hold	66	–	–	﹤0.01%	837
2023 Q1	$2.52K	Hold	66	–	–	﹤0.01%	778
2022 Q4	$3.75K	Buy	+66	New	+$3.38K	﹤0.01%	821
2022 Q3	–	Sell	-66	Closed	-$3K	–	559
2022 Q2	$3K	Hold	66	–	–	﹤0.01%	942
2022 Q1	$3K	Hold	66	–	–	﹤0.01%	1016
2021 Q4	$3K	Hold	66	–	–	﹤0.01%	1055
2021 Q3	$3K	Hold	66	–	–	﹤0.01%	686
2021 Q2	$3K	Hold	66	–	–	﹤0.01%	816
2021 Q1	$3K	Hold	66	–	–	﹤0.01%	756
2020 Q4	$3K	Buy	+66	New	+$2.37K	﹤0.01%	470

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concord Wealth Partners's HALO Position: Q1 2026 in Review

Concord Wealth Partners sold out of Halozyme (HALO) in Q1 2026, closing a stake of 66 shares — an estimated $4.44K sold.

Concord Wealth Partners first reported a position in HALO in Q4 2020 and held it in 20 quarters. The position peaked at $4.84K in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Concord Wealth Partners reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Concord Wealth Partners sold 66 Halozyme shares in Q1 2026, an estimated $4.44K.
Concord Wealth Partners first reported a position in Halozyme in Q4 2020 and held it in 20 quarters.
Concord Wealth Partners's Halozyme position peaked at $4.84K in Q3 2025.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Concord Wealth Partners's 13F filing for Q1 2026, filed 1 May 2026.